CANOPY IMMUNO-THERAPEUTICS
CANOPY IMMUNO-THERAPEUTICS
Industry:
Biotechnology
Founded:
2020-01-01
Total Employee:
1+
Status:
Active
Contact:
+972-51-8187157
Email Addresses:
[email protected]
Similar Organizations
Sound Biotech
Sound Biotech
Current Employees Featured
Founder
More informations about "Canopy Immuno-Therapeutics"
Canopy – Advancing beyond immunosuppression, Striving …
Canopy’s foundation was inspired by Natalie, a 26yo Myasthenia Gravis patient who suffered severe complications from her immunosuppressive therapy, the only available treatment for …See details»
Canopy Immuno-Therapeutics - PitchBook
Jan 1, 2020 Information on valuation, funding, cap tables, investors, and executives for Canopy Immuno-Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Canopy Immuno-Therapeutics - CEO and Investor Conference 2025
Feb 11, 2025 Canopy is an emerging biotech redefining autoimmune therapeutics through its groundbreaking Antigen-Drug Conjugate (AgDC) platform. Backed by leading US-based VCs, …See details»
Canopy Immuno Therapeutics - JLABS Navigator | JLABS
Canopy Immuno Therapeutics is a virtual of JLABS and an of JLABS Singapore. The company focuses on Auto-Antibody PAS within Immunology within Pharmaceuticals.See details»
Canopy Immuno-Therapeutics - Israeli Startup
Nov 19, 2020 Canopy is a pre-clinical stage biotech developing a new class of biologics that will allow the elimination of antigen-specific immunity, providing non-immunosuppressive, potentially curing treatments to many …See details»
Canopy Immuno-Therapeutics - Crunchbase …
Jan 1, 2020 Frequently Asked Questions Who are Canopy Immuno-Therapeutics's competitors? Alternatives and possible competitors to Canopy Immuno-Therapeutics may include Ganymede, RegDesk, and LARRK Bio.See details»
Canopy Immuno - Therapeutics Ltd. - Drug pipelines, Patents, …
May 7, 2025 Explore Canopy Immuno - Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Hemic and Lymphatic Diseases, Technology ...See details»
Canopy | TLV Partners
Canopy is a preclinical biotech that is focused on disrupting the Immunology space by building a first-of-its-kind ‘Reverse Immunization’ technology to create non-immunosuppressive, …See details»
CANOPY IMMUNO-THERAPEUTICS LTD - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CANOPY IMMUNO-THERAPEUTICS LTD of MEGADIM, Sharon Area. Get the latest business insights …See details»
Canopy Immuno-Therapeutics - TwoInstitute
About Canopy Immuno-Therapeutics is Pharmaceuticals in Israel that focus on developer business. Founded in 2019. They cover business area such as developer, an …See details»
Fighting AMR with Host Immune Response Technology - PMC
Last year, he founded Canopy Immuno-Therapeutics, a stealth mode biotech company engaged in developing a novel immunotherapeutic approach for autoimmunity and life-threatening allergy.See details»
Canopy Immuno-Therapeutics - StartupHub.ai
About Canopy Immuno-Therapeutics A stealth mode biotech company engaged in the development of novel immunotherapeutic approach for autoimmunity and life-threatening allergy.See details»
WO2024231931 - Drug Targets, Indications, Patents - Synapse
WO2024231931, Initially developed by Canopy Immuno - Therapeutics Ltd., Now, its global highest R&D status is Discovery, Therapeutic Areas: Immune System Diseases,Hemic and …See details»
Kfir Oved - CEO and Investor Conference 2025
Feb 11, 2025 In 2020, he founded Canopy Immuno-Therapeutics, a stealth-mode biotechnology company focused on developing a groundbreaking immunotherapeutic platform targeting …See details»
AI in medical diagnosis and treatment | TLV Partners
Sep 30, 2020 Canopy Immuno-Therapeutics is in stealth mode, so we can only provide a teaser about its mission and its incredible founder. Canopy is a pre-clinical biotech company engaged …See details»
Kfir Oved - Co-founder, CTO, Chairman @ MeMed - Crunchbase
Kfir Oved has 3 current jobs including CEO, Founder at Canopy Immuno-Therapeutics, CSIO at Navina, and Co-founder, CTO, Chairman at MeMed.See details»
WO2024231929 - Drug Targets, Indications, Patents - Synapse
WO2024231929, Initially developed by Canopy Immuno - Therapeutics Ltd., Now, its global highest R&D status is Discovery, Therapeutic Areas: Immune System Diseases,Urogenital …See details»
A Giant Leap for Humanity: The Significance of AI in Medical …
Sep 30, 2020 On Canopy Immuno-Therapeutics and curing disease: Canopy Immuno-Therapeutics is in stealth mode, so we can only provide a teaser about its mission and its …See details»
Kfir Oved - BIO International Convention 2025
In 2020, he founded Canopy Immuno-Therapeutics, a stealth-mode biotechnology company focused on developing a groundbreaking immunotherapeutic platform targeting autoimmune …See details»
Kfir Oved - Lynx Events
Kfir has over 15 years of combined industry and academic experience, leading interdisciplinary and multicultural teams combining Applied Immunology, Biochemistry, Engineering, Big Data, …See details»